SENOLYTIC THERAPEUTICS
Senolytic Therapeutics is a operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.
SENOLYTIC THERAPEUTICS
Social Links:
Industry:
Alternative Medicine Biopharma Biotechnology Medical Medical Device Pharmaceutical Robotics
Founded:
2017-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.senolytx.com
Total Employee:
1+
Status:
Active
Contact:
34607046707
Total Funding:
583.3 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Dyn DNS
Similar Organizations
Nanoform Therapeutics
Nanoform Therapeutics develops new generation of Bio-Pharmaceutical developmental or marketed drugs.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Senolytic Therapeutics
Official Site Inspections
http://www.senolytx.com
- Host name: 104.21.39.148
- IP address: 104.21.39.148
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Senolytic Therapeutics"
Senolytic Therapeutics - Crunchbase Company Profile & Funding
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. Senolytic Therapeutics is a operator of a โฆSee details»
Senolytic Therapeutics - LinkedIn
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. STXโs mission is to advance our portfolio of therapies to clinical...See details»
Senolytic Therapeutics - VentureRadar
"Senolytic Therapeutics (STX) is a biotech company developing novel medicines by targeting cellular senescence. We have developed a unique technological portfolio which is based on โฆSee details»
Senolytic Therapeutics - Senolytics - lifespan
Senolytic Therapeutics is developing proprietary strategies to destroy the senescent cells that generate the senescence-associated secretory phenotype (SASP) and harm tissues, thus โฆSee details»
Send in the senolytics | Nature Biotechnology
Nov 12, 2020ย ยท Despite early failures in the clinic, the idea of anti-aging therapies that purge the body of dying cells is gaining traction with a raft of startups now focused on senescence. Unity โฆSee details»
Senolytx Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Senolytx. Use the PitchBook Platform to explore the full profile.See details»
Senolytic Therapeutics - Craft
See insights on Senolytic Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Senolytx Therapeutics & How they Are Tackling Senescent Cells
Tim Cash is the Chief Scientific Officer of Senolytx Therapeutics, a biotech company developing novel medicines to improve and extend human lives by targeting senescent cells. One of the โฆSee details»
Senolytic Therapeutics - Company Profile & Staff Directory
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. STXโs mission is to advance our portfolio of therapies โฆSee details»
Senolytic drugs boost key protective protein - Mayo โฆ
May 18, 2022ย ยท Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that may protect older people against aspects of aging and a range of diseases. Their findings, which are published in eBioMedicine โฆSee details»
Senolytx - SOMMa
Senolytx was born in the year 2017, fruit of the research led by Manuel Serrano. Selenolytic Therapeutics focuses on the removal of senescent cells for the treatment of diseases related โฆSee details»
Senolytx - EU-Startups
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. STXโs mission is to advance our portfolio of therapies โฆSee details»
senolytx
๋จนํ๊ฒ์ฆ์ด๋ ์จ๋ผ์ธ ์คํฌ์ธ ๋ฐฐํ ์ฌ์ดํธ๋ ์นด์ง๋ ธ ์ฌ์ดํธ ๋ฑ์์ ๋ฐ์ํ ์ ์๋ ๋จนํ ํ์๋ฅผ ์ฌ์ ์ ์๋ฐฉํ๊ณ , ํผํด๋ฅผ ์ต์ํํ๊ธฐ ์ํด ์ฌ์ดํธ์ ์ ๋ขฐ์ฑ๊ณผ ์์ ์ฑ์ ๋ฉด๋ฐํ ์กฐ์ฌํ๊ณ ๊ฒํ ํ๋ ๊ณผ์ ์ โฆSee details»
First-in-human trial of senolytic drugs encouraging - Medical Xpress
Jan 7, 2019ย ยท UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly โฆSee details»
#018: A Tour of All Senolytics Companies. - Longevity Marketcap
Dec 15, 2020ย ยท Senolytx Therapeutics and How they Are Tackling Senescent Cells: Simple BioTech Podcast #1 General Notes Senolytic Therapeutics develops small molecule drug โฆSee details»
Senolytic Therapeutics - Ventures & Markets - LONGECITY
Mar 14, 2019ย ยท Senolytic Therapeutics - posted in Ventures & Markets: http://senolytx.com/ Our academic founders have played a key role in demonstrating that senescence occurs in โฆSee details»
Senolytic drugs: from discovery to translation - PubMed
Senolytics are a class of drugs that selectively clear senescent cells (SC). The first senolytic drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis-driven โฆSee details»
Senolytic Therapeutics | VentureRadar
Website: http://senolytx.com/ Develops novel medicines targeting senescent cells to extend healthy lives, focusing on age-related disorders including liver, lung, and kidney fibrosis. โฆSee details»
First evidence that senolytics are effective at decreasing senescent ...
The increasing life expectancy of the world population has become an economic and global public health problem. Increased life expectancy tracks with a higher incidence of multiple chronic โฆSee details»
Senolytic therapies for healthy longevity - PMC
In mice, the selective elimination of SNCs, commonly known as senolysis, extends median lifespan and prevents or attenuates various features of aging and age-related diseases such โฆSee details»